Ron Bentsur
2023 - Nuvectis Pharma
In 2023, Ron Bentsur earned a total compensation of $2.7M as President & Chief Executive Officer at Nuvectis Pharma, a 59% increase compared to previous year.
Compensation breakdown
Bonus | $508,875 |
---|---|
Salary | $615,250 |
Stock Awards | $1,566,600 |
Total | $2,690,725 |
Bentsur received $1.6M in stock awards, accounting for 58% of the total pay in 2023.
Bentsur also received $508.9K in bonus and $615.3K in salary.
Rankings
In 2023, Ron Bentsur's compensation ranked 346th out of 2,785 executives tracked by ExecPay. In other words, Bentsur earned more than 87.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 346 | 88th |
Manufacturing | 198 | 87th |
Chemicals And Allied Products | 137 | 84th |
Drugs | 134 | 84th |
Pharmaceutical Preparations | 82 | 86th |
Bentsur's colleagues
We found two more compensation records of executives who worked with Ron Bentsur at Nuvectis Pharma in 2023.